Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer

Summary

The purpose of this study is to demonstrate that capecitabine/oxaliplatin as perioperative chemotherapy is superior or not to operation directly for locally advanced gastric cancer in terms of 3 year disease-free survival (DFS) rate.

Timeline

Start

2013-09

Primary completion

2020-08

Completion

2022-09

Outcome

Outcome not reported

Stopped: “we are working on a larger similar multicenter cinical trials as a participant.so in order to avoid conflicts of interest, we have to suspended this project.”

Drugs

Indications